Galapagos | Resultat Før Skatt



Pre Tax Profit Endring Dato
argenx SE USD 88.02M 103.02M 2024-09
AstraZeneca USD 3.4B 1.74B 2025-03
Biogen USD 572.2M 118.5M 2024-12
Genmab DKK 3.6B 1.88B 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
GRIFOLS EUR 210.54M 143.56M 2024-12
Hikma Pharmaceutical USD 144M 144M 2024-06
Incyte USD 234.19M 172.64M 2025-03
Merck EUR 809M 425.38M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
UCB EUR 123M 464.07M 2024-06
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Galapagos Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.